0RIA Stock Overview
Operates in the medical imaging industry in France and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Diagnostic Medical Systems S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.82 |
52 Week High | €1.31 |
52 Week Low | €0.80 |
Beta | 1.04 |
11 Month Change | 1.74% |
3 Month Change | -16.36% |
1 Year Change | -22.10% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -76.81% |
Recent News & Updates
Recent updates
Shareholder Returns
0RIA | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 1.7% | -1.6% | 0.8% |
1Y | -22.1% | -4.4% | 6.6% |
Return vs Industry: 0RIA underperformed the UK Medical Equipment industry which returned -4.4% over the past year.
Return vs Market: 0RIA underperformed the UK Market which returned 6.6% over the past year.
Price Volatility
0RIA volatility | |
---|---|
0RIA Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.1% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RIA's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0RIA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 125 | Samuel Sancerni | www.dms.com |
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France and internationally. The company offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, and mobile C-arms solutions. It also provides technologies for the treatment of osteoarthritis, and regenerative medicine based on the injection of fat stem cells.
Diagnostic Medical Systems S.A. Fundamentals Summary
0RIA fundamental statistics | |
---|---|
Market cap | €14.59m |
Earnings (TTM) | -€14.97m |
Revenue (TTM) | €46.53m |
0.3x
P/S Ratio-1.0x
P/E RatioIs 0RIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0RIA income statement (TTM) | |
---|---|
Revenue | €46.53m |
Cost of Revenue | €29.56m |
Gross Profit | €16.96m |
Other Expenses | €31.94m |
Earnings | -€14.97m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.83 |
Gross Margin | 36.46% |
Net Profit Margin | -32.18% |
Debt/Equity Ratio | 114.5% |
How did 0RIA perform over the long term?
See historical performance and comparison